DE
39
3
ORCL
68
-3
CTSH
63
-2
AIV
60
-4
INTC
39
-10
GE
65
-6
URBN
55
-11
ETN
79
-5
NOC
34
-6
FDX
44
-10
IBM
50
-3
EL
20
2
ADT
55
-3
XOM
48
-3
NWL
50
-6
FOX
59
2
NDAQ
59
-4
CHRW
65
-2
CVX
47
9
K
56
-4
DE
39
3
ORCL
68
-3
CTSH
63
-2
AIV
60
-4
INTC
39
-10
GE
65
-6
URBN
55
-11
ETN
79
-5
NOC
34
-6
FDX
44
-10
IBM
50
-3
EL
20
2
ADT
55
-3
XOM
48
-3
NWL
50
-6
FOX
59
2
NDAQ
59
-4
CHRW
65
-2
CVX
47
9
K
56
-4
Financhill
Back

Cytokinetics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
50

CYTK
Cytokinetics

Last Price:
54.71
Seasonality Move:
9.1%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
65.58
Seasonality Move:
13.04%
Sell
50
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $54.70. The Score for CYTK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $65.60. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $54.70
    The current trend is moderately bullish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $65.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.58 Buy
Relative Strength Index (14 RSI): 50.96 Buy
Chaikin Money Flow: -747981 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 56.1) Buy
Bollinger Bands (100): (53.08 - 57.16) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.6 Sell
Relative Strength Index (14 RSI): 33 Sell
Chaikin Money Flow: -1236859 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.39 - 70.27) Sell
Bollinger Bands (100): (69.82 - 87.76) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.91 Sell
20-day SMA: 53.86 Buy
50-day SMA: 54.19 Buy
200-day SMA: 60.4 Sell
8-day EMA: 55.45 Sell
20-day EMA: 54.59 Buy
50-day EMA: 54.52 Buy
200-day EMA: 55.64 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.37 Sell
20-day SMA: 67.86 Sell
50-day SMA: 71.16 Sell
200-day SMA: 81.82 Sell
8-day EMA: 66.45 Sell
20-day EMA: 67.67 Sell
50-day EMA: 71.58 Sell
200-day EMA: 80.4 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $0.11 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):